Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
August 5, 2008
Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
S Cereda, M Reni
Cancer Letters
|
June 15, 2007
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen
M Reni, S Cereda, L Galli
The Journal of Chemical Physics
|
September 14, 2010
A first principles based polarizable O(N) interatomic force field for bulk silica
J R Kermode, S Cereda, P Tangney, et al.
Physical Review Letters
|
March 21, 2008
Thermal-hydrogen promoted selective desorption and enhanced mobility of adsorbed radicals in silicon film growth
S Cereda, F Zipoli, M Bernasconi, et al.
Recent Patents on Drug Delivery & Formulation
|
October 8, 2009
Drug delivery systems for local anesthetics
Eneida de Paula, Cíntia M S Cereda, Giovana R Tofoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients
M Mandalà, M Reni, S Cascinu, et al.
Cancer Chemotherapy and Pharmacology
|
January 4, 2008
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma
M Reni, R Berardi, A Mambrini, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
June 16, 2004
Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice
Daniele R de Araujo, Cíntia M S Cereda, Giovana B Brunetto, et al.
American Journal of Clinical Oncology
|
April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy
M Reni, S Cereda, E Mazza, et al.
Cancer Investigation
|
September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study
M Reni, S Cereda, E Bonetto, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Journal of Chemotherapy (Florence, Italy)
|
August 5, 2008
Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer
S Cereda, M Reni
Cancer Letters
|
June 15, 2007
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen
M Reni, S Cereda, L Galli
The Journal of Chemical Physics
|
September 14, 2010
A first principles based polarizable O(N) interatomic force field for bulk silica
J R Kermode, S Cereda, P Tangney, et al.
Physical Review Letters
|
March 21, 2008
Thermal-hydrogen promoted selective desorption and enhanced mobility of adsorbed radicals in silicon film growth
S Cereda, F Zipoli, M Bernasconi, et al.
Recent Patents on Drug Delivery & Formulation
|
October 8, 2009
Drug delivery systems for local anesthetics
Eneida de Paula, Cíntia M S Cereda, Giovana R Tofoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients
M Mandalà, M Reni, S Cascinu, et al.
Cancer Chemotherapy and Pharmacology
|
January 4, 2008
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma
M Reni, R Berardi, A Mambrini, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
June 16, 2004
Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice
Daniele R de Araujo, Cíntia M S Cereda, Giovana B Brunetto, et al.
American Journal of Clinical Oncology
|
April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy
M Reni, S Cereda, E Mazza, et al.
Cancer Investigation
|
September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding study
M Reni, S Cereda, E Bonetto, et al.
Page
of 3